These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34004525)

  • 1. Effects of age of onset and medication on cognitive performance and quality of life in patients with epilepsy.
    Giménez DeGeorge E; Fullen C; Gess J; Kleiner J; Larson-Prior L
    Epilepsy Behav; 2021 Aug; 121(Pt A):108008. PubMed ID: 34004525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drug effects on subjective and objective cognition.
    Quon RJ; Mazanec MT; Schmidt SS; Andrew AS; Roth RM; MacKenzie TA; Sajatovic M; Spruill T; Jobst BC
    Epilepsy Behav; 2020 Mar; 104(Pt A):106906. PubMed ID: 32006792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
    Feldman L; Lapin B; Busch RM; Bautista JF
    Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized controlled trial.
    Boshuisen K; Lamberink HJ; van Schooneveld MM; Cross JH; Arzimanoglou A; van der Tweel I; Geleijns K; Uiterwaal CS; Braun KP
    Trials; 2015 Oct; 16():482. PubMed ID: 26503021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported quality of life in pharmacoresistant temporal lobe epilepsy: correlation with clinical variables and memory evaluation.
    Alonso-Vanegas MA; Cisneros-Franco JM; Castillo-Montoya C; Martínez-Rosas AR; Gómez-Pérez ME; Rubio-Donnadieu F
    Epileptic Disord; 2013 Sep; 15(3):263-71. PubMed ID: 23906668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
    Luoni C; Bisulli F; Canevini MP; De Sarro G; Fattore C; Galimberti CA; Gatti G; La Neve A; Muscas G; Specchio LM; Striano S; Perucca E;
    Epilepsia; 2011 Dec; 52(12):2181-91. PubMed ID: 22136077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning in community dwelling older adults with chronic partial epilepsy.
    Martin RC; Griffith HR; Faught E; Gilliam F; Mackey M; Vogtle L
    Epilepsia; 2005 Feb; 46(2):298-303. PubMed ID: 15679511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Social cognition and cognitive functions in patients with epilepsy treated with eslicarbazepine acetate].
    Abraira L; Sanabria A; Ortega G; Quintana M; Santamarina E; Salas-Puig J; Toledo M
    Rev Neurol; 2018 Jun; 66(11):361-367. PubMed ID: 29790568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
    Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
    Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting epilepsy-related cognitive problems in clinically referred children with epilepsy: is the WISC-IV a useful tool?
    Sherman EM; Brooks BL; Fay-McClymont TB; MacAllister WS
    Epilepsia; 2012 Jun; 53(6):1060-6. PubMed ID: 22554239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher IQ in juvenile myoclonic epilepsy: Dodging cognitive obstacles and "masking" impairments.
    Rzezak P; Moschetta SP; Mendonça M; Paiva MLMN; Coan AC; Guerreiro C; Valente KDR
    Epilepsy Behav; 2018 Sep; 86():124-130. PubMed ID: 30017836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
    Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
    Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognition in school-aged children with "active" epilepsy: A population-based study.
    Reilly C; Atkinson P; Das KB; Chin RF; Aylett SE; Burch V; Gillberg C; Scott RC; Neville BG
    J Clin Exp Neuropsychol; 2015; 37(4):429-38. PubMed ID: 25921696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile Myoclonic Epilepsy (JME): Neuropsychological Profile and Related Factors with Cognitive Dysfunction.
    Motamedi M; Nasergivehch S; Karamghadiri N; Noroozian M
    Iran J Psychiatry; 2014 Mar; 9(1):14-9. PubMed ID: 25561943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring Working Memory With Digit Span and the Letter-Number Sequencing Subtests From the WAIS-IV: Too Low Manipulation Load and Risk for Underestimating Modality Effects.
    Egeland J
    Appl Neuropsychol Adult; 2015; 22(6):445-51. PubMed ID: 25910198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.